
SeaSpine Holdings Corporation SPNE
Quarterly report 2022-Q3
added 11-03-2022
SeaSpine Holdings Corporation Interest Expense 2011-2026 | SPNE
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense SeaSpine Holdings Corporation
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 5.53 M | 463 K | 302 K | -256 K | 430 K | -264 K | -877 K | -269 K | -4.56 M | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 5.53 M | -4.56 M | 56.1 K |
Quarterly Interest Expense SeaSpine Holdings Corporation
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | -419 K | - | 2 K | - | -231 K | 6.08 M | -159 K | - | 136 K | 14 K | 227 K | - | -97 K | -25 K | 73 K | - | -190 K | -157 K | 20 K | - | 215 K | 185 K | -13 K | - | -59 K | -232 K | 258 K | - | 195 K | -51 K | -721 K | - | -30 K | -22 K | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 6.08 M | -721 K | 200 K |
Interest Expense of other stocks in the Medical devices industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
BioSig Technologies
BSGM
|
23 K | - | 37.08 % | $ 85.7 M | ||
|
Axonics Modulation Technologies
AXNX
|
-2.43 M | - | - | $ 3.31 B | ||
|
Dynatronics Corporation
DYNT
|
410 K | - | 14.99 % | $ 929 K | ||
|
Aziyo Biologics
AZYO
|
-2.76 M | - | 1.37 % | $ 20.5 M | ||
|
Align Technology
ALGN
|
7.68 M | $ 164.69 | -7.13 % | $ 12.3 B | ||
|
Acutus Medical
AFIB
|
5.66 M | - | -26.83 % | $ 2.62 M | ||
|
Sintx Technologies
SINT
|
31 K | $ 2.32 | -4.13 % | $ 6.43 M | ||
|
Allied Healthcare Products
AHPI
|
191 K | - | 3.58 % | $ 2.21 M | ||
|
Sensus Healthcare
SRTS
|
683 K | $ 3.8 | -5.24 % | $ 62 M | ||
|
Alphatec Holdings
ATEC
|
45.9 M | $ 10.95 | -4.99 % | $ 1.64 B | ||
|
Conformis
CFMS
|
2.02 M | - | - | $ 16.4 M | ||
|
TELA Bio
TELA
|
1.29 M | $ 0.66 | -11.27 % | $ 31 M | ||
|
Abbott Laboratories
ABT
|
548 M | $ 105.12 | 0.53 % | $ 183 B | ||
|
Tandem Diabetes Care
TNDM
|
-13 M | $ 21.37 | -8.36 % | $ 1.45 B | ||
|
Cardiovascular Systems
CSII
|
1.63 M | - | 0.15 % | $ 844 M | ||
|
Second Sight Medical Products
EYES
|
947 K | - | -0.97 % | $ 54.4 M | ||
|
Apollo Endosurgery
APEN
|
4.67 M | - | - | $ 475 M | ||
|
Boston Scientific Corporation
BSX
|
349 M | $ 69.36 | -1.15 % | $ 103 B | ||
|
Avinger
AVGR
|
1.72 M | - | -20.74 % | $ 369 K | ||
|
CONMED Corporation
CNMD
|
31.1 M | $ 35.31 | -3.63 % | $ 1.1 B | ||
|
NanoVibronix
NAOV
|
135 K | - | - | $ 1.08 M | ||
|
Neovasc
NVCN
|
133 K | - | - | $ 111 M | ||
|
Viemed Healthcare
VMD
|
252 K | $ 9.26 | 0.43 % | $ 360 M | ||
|
Aethlon Medical
AEMD
|
10.1 K | $ 2.19 | -3.52 % | $ 3.42 M | ||
|
Varex Imaging Corporation
VREX
|
-4.4 M | $ 10.81 | 0.23 % | $ 448 M | ||
|
Edwards Lifesciences Corporation
EW
|
7.2 M | $ 78.73 | -4.1 % | $ 46 B | ||
|
Vivos Therapeutics
VVOS
|
-110 K | $ 1.13 | -5.04 % | $ 5.67 M | ||
|
BIOLASE
BIOL
|
-1 K | - | -13.19 % | $ 166 K | ||
|
Beyond Air
XAIR
|
9 K | $ 0.69 | -0.72 % | $ 46.7 M | ||
|
Xtant Medical Holdings
XTNT
|
4.16 M | $ 0.57 | 0.51 % | $ 76.2 M | ||
|
Zimmer Biomet Holdings
ZBH
|
-31.1 M | $ 88.4 | -0.85 % | $ 18 B | ||
|
AdaptHealth Corp.
AHCO
|
-274 K | $ 11.24 | -1.49 % | $ 1.52 B | ||
|
Penumbra
PEN
|
893 K | $ 335.31 | -0.33 % | $ 13 B | ||
|
OrthoPediatrics Corp.
KIDS
|
6.05 M | $ 15.72 | -3.85 % | $ 369 M | ||
|
Invacare Corporation
IVC
|
28.5 M | - | - | $ 24.7 M | ||
|
Ra Medical Systems
RMED
|
99 K | - | 10.0 % | $ 610 K |